Kymera Therapeutics is a biotech company with promising candidates in its pipeline for inflammatory disorders. Read why KYMR ...

Researchers at the University of Würzburg have discovered a process that breaks down mRNA molecules in the human body ...

Scientists identify β-hydroxybutyrate as a key regulator of protein solubility, offering a novel pathway to combat ...

The Würzburg researchers were the first to observe a degradation process directly coupled to protein production ... Unlike ...

Selective protein degradation by the ubiquitin–proteasome pathway is a fundamental regulatory strategy that fulfils essential roles in various cellular processes. In recognition of the central ...

mediating the signaling pathways for protein degradation and the maintenance of cellular homeostasis. These proteins act as ...

Study finds ketone esters help clear misfolded proteins in preclinical models of aging and Alzheimer’s disease.

Kymera Therapeutics (KYMR) has received a new Hold rating, initiated by BMO Capital analyst, Etzer Darout.Don't Miss our Black Friday ...

The oxygen-sensing protein HIF-1alpha may contribute to worsening pulmonary arterial hypertension (PAH) and is a possible ...